arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Celularity Inc.

CELU Health Care Biotechnology: Pharmaceutical Preparations
$0.97
▼ -4.8% Today
as of Oct 23, 12:16 ET
Last 30 days -29.71% Sep 14 → Oct 23
$0.93 $1.14 $1.35 $1.56 $1.77 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.07
High
$1.08
Low
$1.01
Volume
$144,723
Avg Vol
$1M
Mkt Cap
$45M
P/E (TTM)
—
Beta
—
52w High
$2.55
52w Low
$0.56
Div Yield
—
Shares Out
$29M

Recent Press Releases & News last 60 days · 7 items

Oct 22 · 12:00 PR GlobeNewswire
Celularity Regains Compliance with Nasdaq Periodic Reporting Requirement
Sep 30 · 15:57 PR GlobeNewswire
Celularity Highlights Anticipated Quarter One 2027 Opening of Fontaine Vitale as Strategic Partner
Sep 29 · 12:30 PR GlobeNewswire
Celularity Announces Naveen Jain to Join Board of Directors
▸ Show all 7 press releases & news Free account →

CELU earnings at a glance

The options market is pricing a move of about ±34.4% after the report, a range of roughly $0.64 to $1.30 from today's $0.97. Over its last 1 reports the stock rose the next day 0 times and fell 1, moving ±9.0% on average; after the most recent report on May 9, 2025 it moved -9.0%. That means options currently expect more movement than CELU has typically delivered. Implied volatility is currently 220%. The share price of $0.97 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.56
$2.55
21% of range
Avg surprise (last 0)
—
Avg reaction (last 1)
-9.0%
0% positive
Latest IV / EM
220%
EM ±34.4% · $2 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-4.98$-3.73$-2.48$-1.22$0.03 Actual $0.03Actual $-4.12Actual $-2.72Actual $-4.98Actual $-1.03Actual $-0.30Actual $-0.73Actual $-0.59Actual $-0.84Actual $-1.02Actual $-0.88Actual $0.02 SepMarJunSepMarJunSepDec/2024Mar/2025Jun/2025Sep/2025Mar
Revenue vs Net Income Revenue Net income
$-25M$-15M$-6M$3M$13M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Mar 31, 2026Mar 2026 $0.02 — — — — financials
Fri Nov 14, 2025Sep/2025 $-0.88 — — — — earnings
Fri Aug 29, 2025Jun/2025 $-1.02 — — — — earnings
Fri Aug 29, 2025Mar/2025 $-0.84 — — — — earnings
Fri May 9, 2025Dec/2024 $-0.59 — — — -9.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.73 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.30 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.03 — — — — financials
Sat Sep 30, 2023Sep 2023 $-4.98 — — — — financials
Fri Jun 30, 2023Jun 2023 $-2.72 — — — — financials
Fri Mar 31, 2023Mar 2023 $-4.12 — — — — financials
Fri Sep 30, 2022Sep 2022 $0.03 — — — — financials
Thu Jun 30, 2022Jun 2022 $0.32 — — — — financials
Thu Mar 31, 2022Mar 2022 $-0.48 — — — — financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$4M—$5M$6M$11M—$9M$12M
Cost of revenue$1M—$4M$5M$4M—$4M$2M
Gross profit————————
Operating income$-10M—$-13M$-16M$-10M—$-12M$-10M
Net income$874,000—$-23M$-25M$-20M—$-16M$-6M
EPS (diluted)$0.02—$-0.88$-1.02$-0.84—$-0.73$-0.30

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$368,000$6M$120,000$863,000$293,000$738,000$133,000$467,000
Inventory$477,000$571,000$3M$4M$6M$5M$4M$3M
Total current assets$6M$12M$11M$17M$22M$21M$15M$18M
Total assets$99M$107M$114M$120M$129M$133M$129M$135M
Long-term debt————————
Total liabilities$135M$145M$134M$146M$134M$124M$112M$108M
Total equity$-35M$-38M$-20M$-25M$-6M$9M$17M$28M

Implied volatility — last 90 days

189%3107%6026%8944%11863% Jun 07 — IV 2814% · EM ±389.8%Jun 08 — IV 3130% · EM ±413.4%Jun 09 — IV 3974% · EM ±497.9%Jun 10 — IV 3940% · EM ±465.4%Jun 11 — IV 4358% · EM ±481.6%Jun 12 — IV 4936% · EM ±505.0%Jun 15 — IV 6730% · EM ±486.8%Jun 16 — IV 8043% · EM ±475.0%Jun 17 — IV 10522% · EM ±439.4%Jun 19 — IV 2226% · EM ±491.8%Jun 22 — IV 2338% · EM ±488.1%Jun 23 — IV 2514% · EM ±514.4%Jun 24 — IV 2732% · EM ±547.2%Jun 25 — IV 2839% · EM ±556.1%Jun 26 — IV 3202% · EM ±612.9%Jun 29 — IV 3630% · EM ±643.2%Jun 30 — IV 3788% · EM ±652.3%Jul 01 — IV 3863% · EM ±645.4%Jul 02 — IV 3791% · EM ±613.2%Jul 03 — IV 3924% · EM ±613.2%Jul 06 — IV 3707% · EM ±513.5%Jul 07 — IV 3751% · EM ±495.4%Jul 08 — IV 4048% · EM ±507.2%Jul 09 — IV 4075% · EM ±481.4%Jul 10 — IV 4278% · EM ±472.7%Jul 13 — IV 5549% · EM ±463.5%Jul 14 — IV 6409% · EM ±463.6%Jul 15 — IV 8032% · EM ±474.4%Jul 16 — IV 10911% · EM ±455.7%Jul 20 — IV 2062% · EM ±487.2%Jul 21 — IV 2018% · EM ±469.1%Jul 22 — IV 1962% · EM ±448.7%Jul 23 — IV 2048% · EM ±460.5%Jul 24 — IV 2112% · EM ±466.7%Jul 27 — IV 2296% · EM ±479.4%Jul 28 — IV 2251% · EM ±460.5%Jul 29 — IV 2533% · EM ±507.4%Jul 30 — IV 2703% · EM ±529.4%Jul 31 — IV 2961% · EM ±566.7%Aug 03 — IV 3334% · EM ±590.7%Aug 04 — IV 3055% · EM ±526.0%Aug 05 — IV 3017% · EM ±503.9%Aug 06 — IV 3259% · EM ±527.1%Aug 07 — IV 3548% · EM ±554.4%Aug 10 — IV 3785% · EM ±524.3%Aug 11 — IV 4001% · EM ±528.4%Aug 12 — IV 4280% · EM ±536.2%Aug 13 — IV 4505% · EM ±532.1%Aug 14 — IV 4943% · EM ±546.1%Aug 17 — IV 6537% · EM ±546.0%Aug 18 — IV 6756% · EM ±488.7%Aug 19 — IV 7617% · EM ±449.9%Aug 20 — IV 11863% · EM ±495.4%Aug 24 — IV 2132% · EM ±445.3%Aug 25 — IV 2089% · EM ±427.4%Aug 26 — IV 2056% · EM ±411.8%Aug 27 — IV 240% · EM ±47.1%Aug 28 — IV 444% · EM ±84.9%Aug 31 — IV 345% · EM ±61.1%Sep 01 — IV 315% · EM ±54.2%Sep 02 — IV 346% · EM ±57.8%Sep 03 — IV 402% · EM ±65.0%Sep 04 — IV 362% · EM ±56.5%Sep 07 — IV 408% · EM ±56.5%Sep 08 — IV 369% · EM ±48.7%Sep 09 — IV 443% · EM ±55.6%Sep 15 — IV 1003% · EM ±72.6%Sep 17 — IV 1414% · EM ±59.1%Sep 21 — IV 425% · EM ±88.7%Sep 24 — IV 195% · EM ±38.2%Sep 25 — IV 189% · EM ±36.2%Sep 29 — IV 254% · EM ±43.8%Sep 30 — IV 258% · EM ±43.2%Oct 02 — IV 220% · EM ±34.4%

Sector peers

HOWL
Werewolf Therapeutics, Inc.
$45M $1.02-1.0%
VERU
Veru Inc.
$44M $2.300.0%
EDSA
Edesa Biotech, Inc.
$46M $2.70-5.3%
FLNA
Filana Therapeutics, Inc.
$47M $0.64-2.4%
GRCE
Grace Therapeutics, Inc.
$43M $1.90-3.8%
CRVO
CervoMed Inc.
$48M $2.27-3.0%

CELU earnings FAQ

What is CELU's expected move for earnings?

Options currently price a move of about ±34.4%, or $0.33 per share either way from $0.97.

How does CELU stock usually react to earnings?

Across the last 1 reports the average next-day move was ±9.0%, up 0 times and down 1 times.

What is CELU's implied volatility?

CELU's at-the-money implied volatility is about 220% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in